COVID-19 latest

Daily COVID-19 cases update. Photo: Stock/Canva

COVID-19 latest: SA reports 262 new reported cases, 8 deaths

The National Institute for Communicable Diseases (NICD) said that on Sunday, eight deaths were recorded, bringing the fatalities to 89 484.

COVID-19 latest

Daily COVID-19 cases update. Photo: Stock/Canva

South Africa recorded 262 new cases of COVID-19 in the last 24 hours, the National Institute for Communicable Diseases (NICD) has said on Sunday. 


This brings the total number of laboratory-confirmed cases to 2 925 939. 

This increase of 262 new COVID-19 cases represents a 1.1 % positivity rate. 

A further eight COVID-19 related deaths have been reported, bringing total fatalities to 89 484 to date.

COVID-19 latest
Photo: Facebook

“The cumulative number of recoveries is 2 819 688, which is 96.4% recovery rate.” 

The majority of new COVID-19 cases is in Gauteng: 126, followed by KwaZulu-Natal with 39 new cases, Western Cape with 30, and the Free State with 20 new cases provinces. 

For more detailed information, visit the GIS Dashboard.

18 917 933 tests have been conducted in both the public and private sectors.


Here’s some good news on the COVID-19 and vaccine rollout front. As of this weekend, the country has officially fully vaccinated one-third of all South African adults.

ALSO READ: Vaccine Rollout: SA hits milestone with 1 in 3 adults now fully vaxxed

While it’s still well short of the original target of having 70% of adults fully vaxxed for COVID-19 by December, it’s still an important milestone to celebrate.

The focus for the government will not be to make sure that as many adults over 50 who have been hesitant go and get their shots before the 4th wave begins.

Meanwhile, Oramed Pharmaceuticals confirmed last month that the South African Health Products Regulatory Authority had given permission for the trial to go ahead.

The trial will be run in Johannesburg and see just 24 volunteers take the company pill vaccine for COVID-19. Oramed told the Sunday Times that results from the trial are expected halfway through next year.

ALSO READ: Do you qualify for the COVID-19 grant? Here are the eligibility criteria